Earnings Estimate

Search documents
Marathon Digital (MARA) Up 3.9% Since Last Earnings Report: Can It Continue?
ZACKS· 2025-03-28 16:35
Core Viewpoint - Marathon Digital Holdings, Inc. (MARA) has seen a 3.9% increase in share price over the past month, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Earnings Estimates - Analysts have not made any earnings estimate revisions in the last two months, resulting in a consensus estimate shift of -216.67% [2] VGM Scores - Marathon Digital holds a poor Growth Score of F, a Momentum Score of F, and a Value Score of F, placing it in the lowest quintile for investment strategies, with an overall aggregate VGM Score of F [3] Outlook - The company has a Zacks Rank of 3 (Hold), indicating an expectation of an in-line return from the stock in the upcoming months [4]
Kroger Q4 Earnings Top Estimates, Digital Sales Rise 11% Y/Y
ZACKS· 2025-03-06 18:20
The Kroger Co. (KR) reported fourth-quarter fiscal 2024 results, with the top line missing the Zacks Consensus Estimate but the bottom line exceeding the same. However, both metrics declined year over year. Management announces guidance for fiscal 2025.Kroger’s fiscal 2024 results highlight the resilience of its value creation model, driving solid performance and strong free cash flow. Strategic investments have diversified the business, supporting sustainable growth. With a strengthened balance sheet, Krog ...
Analysts Estimate Quanex Building Products (NX) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-03-03 16:00
Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Quanex Building Products despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to show a quarterly loss of $0.06 per share, reflecting a year-over-year change of -133.3%, while revenues are projected to be $381.2 million, an increase of 59.4% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 4% lower in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, which complicates predictions of an earnings beat [10][11]. Historical Performance - Quanex has a history of beating consensus EPS estimates, having done so in the last four quarters, including a +15.09% surprise in the last reported quarter [12][13]. Stock Movement Factors - An earnings beat or miss may not solely dictate stock movement, as other factors can influence investor sentiment [14].
Marvell Technology (MRVL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2025-02-26 16:05
Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Marvell Technology, driven by higher revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - Marvell is expected to report quarterly earnings of $0.59 per share, reflecting a year-over-year increase of +28.3% [3]. - Revenues are projected to reach $1.8 billion, which is a 26.5% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - A positive Earnings ESP of +2.77% suggests that analysts have recently become more optimistic about Marvell's earnings prospects [10]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Marvell currently holds a Zacks Rank of 2, indicating a high likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Marvell exceeded the expected earnings of $0.40 per share by delivering $0.43, resulting in a surprise of +7.50% [12]. - Over the past four quarters, Marvell has beaten consensus EPS estimates three times [13]. Conclusion - While an earnings beat is a positive indicator, other factors may also influence stock movement, making it essential to consider the broader context [14][16]. - Marvell is viewed as a compelling candidate for an earnings beat, but investors should remain aware of additional influencing factors [16].
Acadia Healthcare to Report Q4 Earnings: Can it Overcome Rising Costs?
ZACKS· 2025-02-26 13:25
Core Viewpoint - Acadia Healthcare Company, Inc. is expected to report its fourth-quarter 2024 results on February 27, 2025, with earnings estimated at 72 cents per share and revenues of $779.89 million, indicating a year-over-year revenue growth of 5% despite a decline in earnings per share [1][2]. Financial Estimates - The fourth-quarter earnings estimate has decreased by 2 cents per share over the past 60 days, reflecting a year-over-year decrease of 15.3% in earnings [2]. - For the full year 2024, the revenue estimate for Acadia Healthcare is $3.16 billion, representing a year-over-year increase of 7.9%, while the EPS estimate is $3.38, indicating a decline of approximately 1.7% year-over-year [3]. Recent Performance - Acadia Healthcare has consistently beaten consensus earnings estimates in the last four quarters, with an average surprise of 3.9% [3]. - However, the current model indicates uncertainty regarding an earnings beat for the upcoming quarter, as the company has an Earnings ESP of -5.44% and a Zacks Rank of 4 (Sell) [4]. Revenue Drivers - Revenue estimates for Acute Inpatient Psychiatric Facilities are projected to increase nearly 6% from the previous year's figure of $375.6 million, while Residential Treatment Centers are expected to see a 23% increase from $84.3 million [6]. - U.S. same-facility patient days are anticipated to grow by 4% year-over-year, with admissions expected to rise by 3.1% [7]. Expense Considerations - Rising expenses are likely to impact profit levels, with total expenses expected to increase by more than 6% in the upcoming quarter due to higher salaries, professional fees, and operating costs [8]. - Supply costs are also projected to rise due to increased utilization [8]. Other Revenue Insights - Revenue estimates for Specialty Treatment Facilities are expected to decrease by nearly 2% from $151.3 million, and Comprehensive Treatment Centers are projected to see a 1.2% decline from $131.6 million [9].